LEO PHARMA A/S

Leo Pharma A/S focuses on inflammatory skin disease research centered on atopic dermatitis, including moderate-to-severe disease in adults, children, and infants. Its portfolio also includes work in atopic hand eczema, reflecting interest in difficult-to-treat eczematous conditions with substantial symptom burden and impact on daily function.

• Moderate-to-severe atopic dermatitis
• Atopic hand eczema
• Paediatric and infant skin disease
• Itch, scratching, and skin barrier function

Research activity in this area includes biologic and topical approaches aimed at controlling skin inflammation, improving lesion extent and symptom severity, and addressing quality-of-life effects in younger patients and caregivers.